Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384722 · ClinicalTrials.gov registry record · Phase 2
EASYTRAK 3 Downsize Lead
A Phase 2 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT00384722 is a Phase 2 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 70 participants.
The verdict
NCT00384722, a Phase 2 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the EASYTRAK 3 Downsize Lead.
Interventions
- DEVICE EASYTRAK 3 Downsize Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00384722
The ClinicalTrials.gov registry entry for NCT00384722 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EASYTRAK 3 Downsize Lead is the first listed.
NCT00384722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00384722 about?
NCT00384722 is a clinical study titled "EASYTRAK 3 Downsize Lead". The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the EASYTRAK 3 Downsize Lead.
What is the current status of trial NCT00384722?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2006-03. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00384722?
The interventions under investigation include: EASYTRAK 3 Downsize Lead (DEVICE).
Who is sponsoring clinical trial NCT00384722?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.